Fig. 1 · Structure
Documents & Downloads
BDP8900
Cdc42-binding kinase Inhibitor
BDP8900 is a potent and selective inhibitor of Cdc42-binding kinases, specifically targeting MRCKα and MRCKβ. This compound effectively reduces substrate phosphorylation, resulting in altered cellular morphology, decreased motility, and diminished invasiveness of cancer cells. BDP8900 is suitable for research applications investigating the role of MRCK in oncogenic processes and cellular behavior.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2226507-05-5 |
| Applications | Cdc42-binding kinase Inhibitor |
| Formula | C19H23N5S |
| Molecular Weight | 353.48 |
| SMILES | N1(C2=CC=NC3=C2C(C4=NC=CS4)=CN3)C[C@]5(CCCCN5)CCC1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.